超越输血细胞形成以促进CAR NK/T细胞疗法
Faezeh Ramezani1,2, Ahmad Reza Panahi Meymandi3, Behnia Akbari3
1Division of Medical Biotechnology, Department of Medical Laboratory Sciences, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Molecular cancer
|November 17, 2023
概括
细胞碎片的交换,可限制癌症的CAR T/NK细胞治疗. 调节这一过程的策略对于提高CAR T/NK细胞的持久性和免疫治疗中的有效性至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 癌症治疗 癌症治疗
背景情况:
- 化学抗原受体 (CAR) T和NK细胞疗法在癌症治疗方面表现有前途.
- 细胞膜碎片的细胞间交换,即巨细胞,可以阻碍CAR T/NK细胞的疗效.
研究的目的:
- 审查细胞形成对CAR T/NK细胞治疗的影响.
- 探索调节输血细胞的策略,以改善治疗结果.
主要方法:
- 深入分析细胞瘤对CAR T/NK细胞功能的影响.
- 对免疫疗法中细胞瘤现有文献的综述.
- 探索新策略以准或利用输血细胞.
主要成果:
- 巨细胞症可能会导致癌细胞的暂时抗原损失,从而降低CAR T/NK细胞效应因子的功能.
- 兄弟杀伤和CAR表达细胞的枯竭与细胞结合有关.
- 巨细胞形成会影响CAR T/NK细胞的信号传递和目标分子的获取.
结论:
- 调节输血细胞形成是克服CAR T/NK细胞治疗局限性的关键.
- 向与高细胞化相关的分子和工程CAR细胞可以增强治疗.
- 克服输血细胞的负面影响可能会释放CAR T/NK细胞免疫疗法的全部潜力.
相关概念视频
01:27Tumor Immunotherapy
530
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
530
01:27Cytotoxic T Cells-mediated Immune Response
924
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
924